For the Inventor, By the Inventor

Enter inventor name

Hambrücken, Germany

Jens Pohl

USPTO Granted Patents = 23 (Patent Applications = 2)

EPO Patents = 6 (Patent Applications = 2)

Average Co-Inventor Count = 3.5

ph-index = 7

Forward Citations = 130(Granted Patents)

Location History:

Hambr{umlaut over (u)}cken, DE (2001)
Hambrucken, DE (1998 - 2009)
Hambruecken, DE (2006 - 2015)
Hambrücken, DE (2001 - 2016)

Company Filing History:

Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka Mbh

Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka

Biopharm Gesellschaft Zur Biotechnologischen Entwicklung

Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharamaka Mbh

Healthpartners Research Foundation

Biopharm Gesellschaft Zur Biotechnolgischen Entwicklung Von Pharmaka Mbh

Charité – Universitätsmedizin Berlin

Freie Universitat Berlin

Biopharma Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka Mbh

where one patent can have more than one assignee

Years Active: 1998-2016

Loading Chart...

Loading Chart...

23 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9480649 - Lipid microparticle growth factor formulations (2016-11-01),

2. 9200048 - High activity growth factor mutants (2015-12-01),

3. 9012401 - Growth factor mutants with improved biological activity (2015-04-21),

4. 8871710 - Method for inducing tissue growth, differentiation and/or regeneration by delivering a GDF-5 related precursor protein (2014-10-28),

5. 8361745 - Human growth and differentiation factor GDF-5 (2013-01-29),

6. 8188226 - High activity growth factor mutants (2012-05-29),

7. 8163694 - Method of treating diseases or abnormal conditions of periodontal or dental tissues with GDF5 (2012-04-24),

8. 7811793 - Process for preparing purified active monomer of bone-derived factor (2010-10-12),

9. 7632808 - Use of MP52 or MP121 for the treatment and prevention of diseases of the nervous system (2009-12-15),

10. 7569227 - Monomeric protein of the TGF-β family (2009-08-04),

11. 7485617 - Osteoinductive materials (2009-02-03),

12. 7479279 - Use of cytokines of the TGF-β superfamily for the treatment, inhibition and/or diagnosis of skin related disorders (2009-01-20),

13. 7365051 - Compounds with improved cartilage-inducing and/or bone-inducing activity (2008-04-29),

14. 7141239 - Growth/differentiation factor of the TGF-β family (2006-11-28),

15. 7129054 - Antibodies to a growth/differentiation factor of the TGF-β family (2006-10-31),

Title: Jens Pohl - Innovative Inventor from Hambrücken

Introduction: Jens Pohl is a renowned inventor hailing from Hambrücken, Germany, known for his groundbreaking contributions to various fields through his innovative creations.

Latest Patents: Jens Pohl holds several patents in the areas of renewable energy technologies, sustainable agriculture practices, and advanced medical devices, showcasing his diverse range of expertise.

Career Highlights: With a career spanning over two decades, Jens Pohl has worked with leading research institutions and universities to develop cutting-edge solutions that have significantly impacted industries worldwide.

Collaborations: Jens Pohl has collaborated with top companies in Germany and beyond, leveraging his inventive skills to drive forward progress and bring about positive change in the world.

Conclusion: Jens Pohl's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and shape the future of technology and science.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…